From designing new clinical trials, to finding solutions to statistical and regulatory issues when trials run into roadblocks, to assisting with FDA submissions, clients rely on our experience, expertise, and innovative thinking to deliver reliable results. We specialize in human clinical trials of medical devices as well as academic research projects.

 
 
biomedical-statistical-consulting-clinical-trials

We design clinical trials

We are specialized in designing clinical trials to secure FDA approval of a drug or medical device.

We use innovative novel approaches such as Bayesian design, adaptive clinical trial design, and Propensity Score Matching to save costs, work around limited access to new data, and reduce bias in non- randomized studies.

We have an unmatched track record in orthopedics in particular.

 
biomedical-statistical-consulting-analysis-cinical-trials

We analyze clinical trials

We analyze on-going clinical trial submissions and/or after completion. This includes conducting routine analyses such as Annual Reports, providing Tables, Listings, and Figures (TLF), as well as situation-specific analyses of more complex issues.

We provide sound and trustworthy guidance on how to proceed should statistical or regulatory complexities arise during a clinical trial.

Strategic statistical guidance in the design phase of clinical trials in order to put them in the best possible position for regulatory success. Contact us and we will tailor a proposal that suits you and meets your company’s needs.

Expert review of proposed clinical trial design, reporting and presentation.

 
biomedical-statistical-consulting-results-cinical-trials

We present the results of clinical trials

Submission of clinical trial results to the FDA in accordance with regulators’ expectations.

We work directly with sponsors and in collaboration with clinical research organizations and regulatory advisors.

We respond to inquiries and represent clients in FDA proceedings from pre-Submission through panel meetings.

We are trusted and respected by the FDA. Our founder, Greg Maislin, has participated in three of the FDA’s last three orthopedic panels, which reviewed the Barricaid annular closure device, the Cartiva Synthetic Cartilage Implant, and the Vertiflex Superion Implant.

 
biomedical-statistical-consulting-publish-medical-research

We publish cutting-edge medical research

Data analysis and co-authorship articles in top medical journals with academics and industry leaders.

Collectively, BSC™ team has published over 250 articles in journals including the Proceedings of the The American Journal of Medicine, American Journal of Epidemiology, Joint Statistical Meetings, Journal of Spine & Neurosurgery, the New England Journal of Medicine, Sleep, and Quantitative Imaging in Medicine and Surgery.

Collaboration on other non-regulatory projects with industry sponsors, such as white papers and investor communications.